טוען...
Immunotherapy in Pediatric Acute Lymphoblastic Leukemia
The 5-year survival rate for children and adolescents with acute lymphoblastic leukemia (ALL) has improved to more than 90% in high-income countries. However, further increases in the intensity of conventional chemotherapy would be associated with significant adverse effects; therefore, novel approa...
שמור ב:
| הוצא לאור ב: | Cancer Metastasis Rev |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6995750/ https://ncbi.nlm.nih.gov/pubmed/31811553 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10555-019-09834-0 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|